WO2001051083A3 - Innate immunity-stimulating compositions of cpg and saponin and methods thereof - Google Patents
Innate immunity-stimulating compositions of cpg and saponin and methods thereof Download PDFInfo
- Publication number
- WO2001051083A3 WO2001051083A3 PCT/US2001/001046 US0101046W WO0151083A3 WO 2001051083 A3 WO2001051083 A3 WO 2001051083A3 US 0101046 W US0101046 W US 0101046W WO 0151083 A3 WO0151083 A3 WO 0151083A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- saponin
- innate immunity
- cpg
- methods
- stimulating compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01902032A EP1250150A2 (en) | 2000-01-13 | 2001-01-12 | Innate immunity-stimulating compositions of cpg and saponin and methods thereof |
CA002397374A CA2397374A1 (en) | 2000-01-13 | 2001-01-12 | Innate immunity-stimulating compositions of cpg and saponin and methods thereof |
AU27877/01A AU781812B2 (en) | 2000-01-13 | 2001-01-12 | Innate immunity-stimulating compositions of CPG and saponin and methods thereof |
JP2001551506A JP2003527352A (en) | 2000-01-13 | 2001-01-12 | Innate immune stimulating compounds of CPG and saponin and methods thereof |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17584000P | 2000-01-13 | 2000-01-13 | |
US60/175,840 | 2000-01-13 | ||
US20085300P | 2000-05-01 | 2000-05-01 | |
US60/200,853 | 2000-05-01 | ||
US36994100A | 2000-08-06 | 2000-08-06 | |
US09/369,941 | 2000-08-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001051083A2 WO2001051083A2 (en) | 2001-07-19 |
WO2001051083A3 true WO2001051083A3 (en) | 2002-01-03 |
Family
ID=27390599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/001046 WO2001051083A2 (en) | 2000-01-13 | 2001-01-12 | Innate immunity-stimulating compositions of cpg and saponin and methods thereof |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2003527352A (en) |
AU (1) | AU781812B2 (en) |
CA (1) | CA2397374A1 (en) |
WO (1) | WO2001051083A2 (en) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
ES2572834T3 (en) | 1999-02-17 | 2016-06-02 | Csl Limited | Immunogenic complexes and related methods |
DK1187629T3 (en) | 1999-04-19 | 2005-01-17 | Glaxosmithkline Biolog Sa | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
GB9908885D0 (en) * | 1999-04-19 | 1999-06-16 | Smithkline Beecham Biolog | Vccine |
US20020098199A1 (en) * | 2000-03-10 | 2002-07-25 | Gary Van Nest | Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences |
EA005823B1 (en) | 2000-03-31 | 2005-06-30 | Пердью Рисерч Фаундейшн | Method of treatment using immunogen conjugates |
EP1326638B9 (en) * | 2000-10-18 | 2008-02-20 | GlaxoSmithKline Biologicals S.A. | Vaccines against cancers |
AU2002339224B2 (en) | 2001-09-14 | 2008-10-09 | Kuros Us Llc | Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
KR20040053136A (en) * | 2001-09-28 | 2004-06-23 | 펄듀 리서치 파운데이션 | Method of treatment using ligand-immunogen conjugate |
JP5153990B2 (en) | 2001-12-21 | 2013-02-27 | シーエスエル、リミテッド | Compositions containing immunoreactive reagents and saponins, and methods of use thereof |
CA2388049A1 (en) | 2002-05-30 | 2003-11-30 | Immunotech S.A. | Immunostimulatory oligonucleotides and uses thereof |
JP4598519B2 (en) * | 2002-06-20 | 2010-12-15 | サイトス バイオテクノロジー アーゲー | Packaged virus-like particles for use as adjuvants: preparation and use |
WO2004053104A2 (en) | 2002-12-11 | 2004-06-24 | Coley Pharmaceutical Group, Inc. | 5’ cpg nucleic acids and methods of use |
JP4976848B2 (en) | 2003-02-20 | 2012-07-18 | ユニバーシティー オブ コネティカット ヘルス センター | Methods and compositions for the treatment of cancer and infectious diseases using alpha (2) macroglobulin-antigen molecule complexes |
US8541002B2 (en) | 2003-09-12 | 2013-09-24 | Agenus Inc. | Vaccine for treatment and prevention of herpes simplex virus infection |
US8168164B2 (en) | 2006-02-03 | 2012-05-01 | Purdue Research Foundation | Targeted conjugates and radiation |
RU2015117604A (en) | 2009-04-03 | 2015-10-27 | Эйдженус Инк. | METHODS FOR PRODUCING AND USING MULTI-CHAPERON-ANTIGENIC COMPLEXES |
JP6045895B2 (en) | 2012-10-01 | 2016-12-14 | 株式会社トプコン | Ophthalmic observation device |
JP6925980B2 (en) | 2015-05-13 | 2021-08-25 | アジェナス インコーポレイテッド | Vaccines for the treatment and prevention of cancer |
CA2972175C (en) | 2016-07-29 | 2022-03-01 | Trinidad Schlotterbeck Suarez | Use of quillaja saponaria extracts for the prevention and control of bacterial infections in fish |
WO2018018171A1 (en) | 2016-07-29 | 2018-02-01 | Saponin Research Center S.A. | Use of extracts of quillaja saponaria for the prevention and control of viral infections in fish |
US20200289889A1 (en) | 2019-03-11 | 2020-09-17 | Rom Technologies, Inc. | Bendable sensor device for monitoring joint extension and flexion |
US11185735B2 (en) | 2019-03-11 | 2021-11-30 | Rom Technologies, Inc. | System, method and apparatus for adjustable pedal crank |
US11471729B2 (en) | 2019-03-11 | 2022-10-18 | Rom Technologies, Inc. | System, method and apparatus for a rehabilitation machine with a simulated flywheel |
US11957960B2 (en) | 2019-05-10 | 2024-04-16 | Rehab2Fit Technologies Inc. | Method and system for using artificial intelligence to adjust pedal resistance |
US11801423B2 (en) | 2019-05-10 | 2023-10-31 | Rehab2Fit Technologies, Inc. | Method and system for using artificial intelligence to interact with a user of an exercise device during an exercise session |
US11904207B2 (en) | 2019-05-10 | 2024-02-20 | Rehab2Fit Technologies, Inc. | Method and system for using artificial intelligence to present a user interface representing a user's progress in various domains |
US11071597B2 (en) | 2019-10-03 | 2021-07-27 | Rom Technologies, Inc. | Telemedicine for orthopedic treatment |
US11701548B2 (en) | 2019-10-07 | 2023-07-18 | Rom Technologies, Inc. | Computer-implemented questionnaire for orthopedic treatment |
US11075000B2 (en) | 2019-10-03 | 2021-07-27 | Rom Technologies, Inc. | Method and system for using virtual avatars associated with medical professionals during exercise sessions |
US11955221B2 (en) | 2019-10-03 | 2024-04-09 | Rom Technologies, Inc. | System and method for using AI/ML to generate treatment plans to stimulate preferred angiogenesis |
US11915815B2 (en) | 2019-10-03 | 2024-02-27 | Rom Technologies, Inc. | System and method for using artificial intelligence and machine learning and generic risk factors to improve cardiovascular health such that the need for additional cardiac interventions is mitigated |
US11756666B2 (en) | 2019-10-03 | 2023-09-12 | Rom Technologies, Inc. | Systems and methods to enable communication detection between devices and performance of a preventative action |
US12062425B2 (en) | 2019-10-03 | 2024-08-13 | Rom Technologies, Inc. | System and method for implementing a cardiac rehabilitation protocol by using artificial intelligence and standardized measurements |
US11515021B2 (en) | 2019-10-03 | 2022-11-29 | Rom Technologies, Inc. | Method and system to analytically optimize telehealth practice-based billing processes and revenue while enabling regulatory compliance |
US11955223B2 (en) | 2019-10-03 | 2024-04-09 | Rom Technologies, Inc. | System and method for using artificial intelligence and machine learning to provide an enhanced user interface presenting data pertaining to cardiac health, bariatric health, pulmonary health, and/or cardio-oncologic health for the purpose of performing preventative actions |
US11101028B2 (en) | 2019-10-03 | 2021-08-24 | Rom Technologies, Inc. | Method and system using artificial intelligence to monitor user characteristics during a telemedicine session |
US11069436B2 (en) | 2019-10-03 | 2021-07-20 | Rom Technologies, Inc. | System and method for use of telemedicine-enabled rehabilitative hardware and for encouraging rehabilitative compliance through patient-based virtual shared sessions with patient-enabled mutual encouragement across simulated social networks |
US12020800B2 (en) | 2019-10-03 | 2024-06-25 | Rom Technologies, Inc. | System and method for using AI/ML and telemedicine to integrate rehabilitation for a plurality of comorbid conditions |
US12020799B2 (en) | 2019-10-03 | 2024-06-25 | Rom Technologies, Inc. | Rowing machines, systems including rowing machines, and methods for using rowing machines to perform treatment plans for rehabilitation |
US11955222B2 (en) | 2019-10-03 | 2024-04-09 | Rom Technologies, Inc. | System and method for determining, based on advanced metrics of actual performance of an electromechanical machine, medical procedure eligibility in order to ascertain survivability rates and measures of quality-of-life criteria |
US11887717B2 (en) | 2019-10-03 | 2024-01-30 | Rom Technologies, Inc. | System and method for using AI, machine learning and telemedicine to perform pulmonary rehabilitation via an electromechanical machine |
US11961603B2 (en) | 2019-10-03 | 2024-04-16 | Rom Technologies, Inc. | System and method for using AI ML and telemedicine to perform bariatric rehabilitation via an electromechanical machine |
US11915816B2 (en) | 2019-10-03 | 2024-02-27 | Rom Technologies, Inc. | Systems and methods of using artificial intelligence and machine learning in a telemedical environment to predict user disease states |
US11978559B2 (en) | 2019-10-03 | 2024-05-07 | Rom Technologies, Inc. | Systems and methods for remotely-enabled identification of a user infection |
US11923065B2 (en) | 2019-10-03 | 2024-03-05 | Rom Technologies, Inc. | Systems and methods for using artificial intelligence and machine learning to detect abnormal heart rhythms of a user performing a treatment plan with an electromechanical machine |
US11830601B2 (en) | 2019-10-03 | 2023-11-28 | Rom Technologies, Inc. | System and method for facilitating cardiac rehabilitation among eligible users |
US11955220B2 (en) | 2019-10-03 | 2024-04-09 | Rom Technologies, Inc. | System and method for using AI/ML and telemedicine for invasive surgical treatment to determine a cardiac treatment plan that uses an electromechanical machine |
US11826613B2 (en) | 2019-10-21 | 2023-11-28 | Rom Technologies, Inc. | Persuasive motivation for orthopedic treatment |
TW202128217A (en) | 2019-12-13 | 2021-08-01 | 大陸商遠大賽威信生命科學(南京)有限公司 | Pharmaceutical composition and use thereof |
US11107591B1 (en) | 2020-04-23 | 2021-08-31 | Rom Technologies, Inc. | Method and system for describing and recommending optimal treatment plans in adaptive telemedical or other contexts |
CN113223690B (en) * | 2020-07-06 | 2022-10-11 | 罗姆科技股份有限公司 | Method and system for rehabilitating a subject via telemedicine |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998037919A1 (en) * | 1997-02-28 | 1998-09-03 | University Of Iowa Research Foundation | USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS |
WO1999061056A2 (en) * | 1998-05-22 | 1999-12-02 | Loeb Health Research Institute At The Ottawa Hospital | Methods and products for inducing mucosal immunity |
WO2000009159A1 (en) * | 1998-08-10 | 2000-02-24 | Aquila Biopharmaceuticals, Inc. | Compositions of cpg and saponin adjuvants and methods thereof |
WO2000062800A2 (en) * | 1999-04-19 | 2000-10-26 | Smithkline Beecham Biologicals Sa | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
-
2001
- 2001-01-12 CA CA002397374A patent/CA2397374A1/en not_active Abandoned
- 2001-01-12 AU AU27877/01A patent/AU781812B2/en not_active Ceased
- 2001-01-12 WO PCT/US2001/001046 patent/WO2001051083A2/en not_active Application Discontinuation
- 2001-01-12 JP JP2001551506A patent/JP2003527352A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998037919A1 (en) * | 1997-02-28 | 1998-09-03 | University Of Iowa Research Foundation | USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS |
WO1999061056A2 (en) * | 1998-05-22 | 1999-12-02 | Loeb Health Research Institute At The Ottawa Hospital | Methods and products for inducing mucosal immunity |
WO2000009159A1 (en) * | 1998-08-10 | 2000-02-24 | Aquila Biopharmaceuticals, Inc. | Compositions of cpg and saponin adjuvants and methods thereof |
WO2000062800A2 (en) * | 1999-04-19 | 2000-10-26 | Smithkline Beecham Biologicals Sa | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
Non-Patent Citations (1)
Title |
---|
KIM SOO KIE ET AL: "Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates.", VACCINE, vol. 19, no. 4-5, 15 October 2000 (2000-10-15), pages 530 - 537, XP000999847, ISSN: 0264-410X * |
Also Published As
Publication number | Publication date |
---|---|
CA2397374A1 (en) | 2001-07-19 |
AU781812B2 (en) | 2005-06-16 |
JP2003527352A (en) | 2003-09-16 |
WO2001051083A2 (en) | 2001-07-19 |
AU2787701A (en) | 2001-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001051083A3 (en) | Innate immunity-stimulating compositions of cpg and saponin and methods thereof | |
AU2001227889A1 (en) | Oligodeoxynucleotide and its use to induce an immune response | |
MXPA03002453A (en) | Use of immidazoquinolinamines as adjuvants in dna vaccination. | |
AU2002239273A1 (en) | Fabric softening compositions and methods | |
AU2001269742A1 (en) | Method of treating gastrointestinal diseases associated with species of genus clostridium | |
EP1404182A4 (en) | Pre-proofed freezer-to-oven dough compositions, and methods | |
AU2001285143A1 (en) | Methods and compositions for targeted delivery | |
AU2002353783A1 (en) | SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE | |
AU2001260847A1 (en) | Compositions isolated from skin cells and methods for their use | |
WO2004005476A3 (en) | Nucleic acid compositions for stimulating immune responses | |
RS89204A (en) | Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease | |
AU2001241918A1 (en) | Methods of enhancing activity of vaccines and vaccine compositions | |
MXPA03000488A (en) | Gel form automatic dishwashing compositions, methods of preparation and use thereof. | |
AU2001245987A1 (en) | Compositions and methods for gene therapy | |
AU2002230888A1 (en) | Methods and compositions to treat conditions associated with neovascularization | |
MXPA03003741A (en) | Methods and compositions for the treatment of diseases of the eye. | |
AU2001275155A1 (en) | Superoxide-generating diazeniumdiolates, compositions comprising same, and methods for using same | |
AU5647601A (en) | Hair treatment compositions | |
AU2001222215A1 (en) | Lumbago treating girdle | |
IL144845A0 (en) | Vaccines and gene therapy compositions and methods of making and using the same | |
AU2001245489A1 (en) | Human single nucleotide polymorphisms | |
AU2001240018A1 (en) | Adeno-associated viral compositions and methods | |
AU2003217309A1 (en) | Novel pyranosyl cytosines: pharmaceutical formulations and methods | |
AU2003210704A1 (en) | Lottery game and system | |
AU2002367169A1 (en) | Dualstage extraction blower |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2397374 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 551506 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 27877/01 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001902032 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001902032 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 27877/01 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001902032 Country of ref document: EP |